The findings offer clear evidence that CART plays a beneficial role in improving various cardiometabolic health markers, such as anthropometrics, body composition, lipid profile, fasting glucose levels, and physical function in individuals with T2DM and concomitant overweight/obesity. The gene discussed is CARTPT; the disease is Obesity.